Bibliographic information
GuidelineWHO recommendations on maternal health: guidelines approved by the WHO Guidelines Review Committee, second edition. Geneva: World Health Organization; 2025
Year of Publication2023
Issuing InstitutionWorld Health Organization
Recommendation
Maintained
In settings with a ≥2% or ≥5%% HBsAg seroprevalence in the general population, it is recommended that HBsAg serological testing be routinely offered to all pregnant women in antenatal clinics, with linkage to prevention, care and treatment services. Couples and partners in antenatal care settings should be offered HBV testing services.
Recommended in favor
Strong
Certainty of evidence
Low
Also Featured In
This recommendation also appears in the following guidelines:
Originally Developed
Guideline
WHO guidelines on hepatitis B and C testing.
Year2017
InstitutionWHO
Guideline
Guidelines for the prevention, diagnosis, care and treatment for people with chronic hepatitis B infection.
Year2024
InstitutionWHO